Literature DB >> 25228987

A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures.

Bo Abrahamsen1, Dorthe Brask-Lindemann2, Katrine Hass Rubin3, Peter Schwarz4.   

Abstract

Although many strong risk factors for osteoporosis-such as family history, fracture history and age-are not modifiable, a number of important risk factors are potential targets for intervention. Thus, simple, non-pharmacological intervention in patients at increased risk of osteoporotic fractures could include reduction of excessive alcohol intake, smoking cessation, adequate nutrition, patient education, daily physical activity and a careful review of medications that could increase the risk of falls and fractures. There remains, however, an unmet need for high-quality intervention studies in most of these areas.

Entities:  

Year:  2014        PMID: 25228987      PMCID: PMC4162465          DOI: 10.1038/bonekey.2014.69

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  86 in total

Review 1.  Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis.

Authors:  Karen E Hansen; H Alexander Wilson; Carol Zapalowski; Howard A Fink; Salvatore Minisola; Robert A Adler
Journal:  J Bone Miner Res       Date:  2011-06-30       Impact factor: 6.741

2.  Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women.

Authors:  A G Need; A Kemp; N Giles; H A Morris; M Horowitz; B E C Nordin
Journal:  Osteoporos Int       Date:  2002-01       Impact factor: 4.507

Review 3.  Alcohol and bone: review of dose effects and mechanisms.

Authors:  D B Maurel; N Boisseau; C L Benhamou; C Jaffre
Journal:  Osteoporos Int       Date:  2011-09-17       Impact factor: 4.507

4.  Alcohol intake and its relationship with bone mineral density, falls, and fracture risk in older men.

Authors:  Peggy M Cawthon; Stephanie L Harrison; Elizabeth Barrett-Connor; Howard A Fink; Jane A Cauley; Cora E Lewis; Eric S Orwoll; Steven R Cummings
Journal:  J Am Geriatr Soc       Date:  2006-11       Impact factor: 5.562

5.  Smoking is associated with lower bone mineral density and reduced cortical thickness in young men.

Authors:  Mattias Lorentzon; Dan Mellström; Egil Haug; Claes Ohlsson
Journal:  J Clin Endocrinol Metab       Date:  2006-10-31       Impact factor: 5.958

6.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

7.  Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study.

Authors:  Cynthia de Luise; Michael Brimacombe; Lars Pedersen; Henrik Toft Sørensen
Journal:  Eur J Epidemiol       Date:  2007-11-24       Impact factor: 8.082

Review 8.  Epidemiology and consequences of sarcopenia.

Authors:  G Abellan van Kan
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

Review 9.  Fracture risk associated with smoking: a meta-analysis.

Authors:  P Vestergaard; L Mosekilde
Journal:  J Intern Med       Date:  2003-12       Impact factor: 8.989

Review 10.  Lifestyle and dietary factors determine age at natural menopause.

Authors:  Shilpa Sapre; Ratna Thakur
Journal:  J Midlife Health       Date:  2014-01
View more
  15 in total

1.  Social inequality and fractures-secular trends in the Danish population: a case-control study.

Authors:  L Hansen; A Judge; M K Javaid; C Cooper; P Vestergaard; B Abrahamsen; N C Harvey
Journal:  Osteoporos Int       Date:  2018-06-26       Impact factor: 4.507

2.  Time trends in osteoporosis risk factor profiles: a comparative analysis of risk factors, comorbidities, and medications over twelve years.

Authors:  Jakob Præst Holm; Lars Hyldstrup; Jens-Erik Beck Jensen
Journal:  Endocrine       Date:  2016-05-13       Impact factor: 3.633

3.  e-Cigarette Vapour Condensate Reduces Viability and Impairs Function of Human Osteoblasts, in Part, via a Nicotine Dependent Mechanism.

Authors:  Thomas Nicholson; Lauren Davis; Edward T Davis; Matthew Newton Ede; Aaron Scott; Simon W Jones
Journal:  Toxics       Date:  2022-08-28

4.  Cortical and trabecular morphology is altered in the limb bones of mice artificially selected for faster skeletal growth.

Authors:  Saira Farooq; Shannon Leussink; Leah M Sparrow; Marta Marchini; Hayley M Britz; Sarah L Manske; Campbell Rolian
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

5.  The nicotinic acetylcholine receptor α7 subunit is an essential negative regulator of bone mass.

Authors:  Kazuaki Mito; Yuiko Sato; Tami Kobayashi; Kana Miyamoto; Eriko Nitta; Atsushi Iwama; Morio Matsumoto; Masaya Nakamura; Kazuki Sato; Takeshi Miyamoto
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

6.  Incidence and risk factors for foot fractures in China: A retrospective population-based survey.

Authors:  Song Liu; Yanbin Zhu; Lin Wang; Wei Chen; Xiaolin Zhang; Yingze Zhang
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

Review 7.  Potential mechanisms linking psychological stress to bone health.

Authors:  Jia-Sheng Ng; Kok-Yong Chin
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

Review 8.  The impact of E-cigarette vaping and vapour constituents on bone health.

Authors:  Thomas Nicholson; Aaron Scott; Matthew Newton Ede; Simon W Jones
Journal:  J Inflamm (Lond)       Date:  2021-05-05       Impact factor: 4.981

Review 9.  The Hidden Burden of Fractures in People Living With HIV.

Authors:  Melissa O Premaor; Juliet E Compston
Journal:  JBMR Plus       Date:  2018-06-20

Review 10.  The Interplay between Immune System and Microbiota in Osteoporosis.

Authors:  Pietro Locantore; Valeria Del Gatto; Silvia Gelli; Rosa Maria Paragliola; Alfredo Pontecorvi
Journal:  Mediators Inflamm       Date:  2020-02-26       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.